BRIEF published on 02/03/2026 at 14:04, 5 months 27 days ago JP Morgan reaches new thresholds at DBV Technologies Crossing Thresholds Shares And Voting Rights DBV Technologies JP Morgan Equity Swap Contract
BRIEF published on 01/20/2026 at 11:41, 6 months 10 days ago Thresholds crossed at DBV Technologies by JP Morgan Chase & Co. Shares And Voting Rights DBV Technologies Financial Contracts JP Morgan Participation Thresholds
BRIEF published on 01/20/2026 at 09:20, 6 months 10 days ago DBV Technologies: Thresholds crossed by Bpifrance Investment Crossing Thresholds Shares And Voting Rights Bpifrance DBV Technologies
BRIEF published on 01/20/2026 at 09:17, 6 months 10 days ago Threshold crossings at DBV Technologies Crossing Thresholds Shares And Voting Rights DBV Technologies Caisse Des Dépôts Bpifrance Participations
BRIEF published on 01/17/2026 at 00:16, 6 months 13 days ago DBV Technologies generates €166.7 million through the exercise of Warrants Funding DBV Technologies Food Allergies Viaskin® Peanut Subscription Vouchers
BRIEF published on 01/12/2026 at 22:05, 6 months 17 days ago DBV Technologies: Status of voting rights and shares as of December 31, 2025 Share Capital Voting Rights Actions NYSE Euronext DBV Technologies
BRIEF published on 01/12/2026 at 22:05, 6 months 17 days ago DBV Technologies Updates Voting Rights and Shares as of December 31, 2025 Voting Rights DBV Technologies NYSE Euronext Paris Shares Update December 2025
PRESS RELEASE published on 01/12/2026 at 22:00, 6 months 17 days ago Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 Press release on total number of voting rights and shares of the Company as of December 31, 2025, in compliance with Article 223-16 of AMF General Regulations Voting Rights Shares AMF Regulations NYSE Euronext Paris December 31 2025
BRIEF published on 12/16/2025 at 22:10, 7 months 13 days ago DBV Technologies Reports Positive Phase 3 Results for VIASKIN Peanut Patch Phase 3 Trial Child Health Viaskin Peanut Peanut Allergy BLA Submission
BRIEF published on 12/16/2025 at 22:10, 7 months 13 days ago DBV Technologies: Encouraging Results from the VITESSE Study on the Peanut Allergy Patch DBV Technologies Clinical Results Viaskin Peanut Peanut Allergy SPEED Study
Published on 07/30/2026 at 14:00, 17 minutes ago Tectonic Metals Advances Investor Engagement with Leadership Appointment and Announces Equity Grants
Published on 07/30/2026 at 14:00, 17 minutes ago Horizon Aircraft to Participate in August Investment Conferences
Published on 07/30/2026 at 14:00, 17 minutes ago Rio Grande Resources Announces Market Awareness Initiative and Engages with LFG Equities Corp.
Published on 07/30/2026 at 13:30, 47 minutes ago Alset AI Engages DS Market Solutions to Strengthen Market Liquidity and Support Shareholder Accessibility
Published on 07/30/2026 at 13:04, 1 hour 13 minutes ago Reply S.p.A: The Board of Directors approves the half-year financial report as of 30 June 2026
Published on 07/30/2026 at 12:45, 1 hour 32 minutes ago H&K AG: Significant growth in revenue, total operating performance and EBITDA; full-year guidance raised
Published on 07/30/2026 at 12:45, 1 hour 32 minutes ago EQS-Adhoc: H&K AG: Significant growth in revenue, total operating performance and EBITDA; full-year guidance raised
Published on 07/30/2026 at 12:37, 1 hour 39 minutes ago Zentra Group plc: One Victoria - Contractor Administration and Termination
Published on 07/30/2026 at 09:07, 5 hours 9 minutes ago CNP Assicura, a subsidiary of CNP Assurances in Italy, announces an exclusive partnership with Fineco bank in the life insurance segment
Published on 07/30/2026 at 07:30, 6 hours 47 minutes ago Availability of the 2026 Interim Financial Report
Published on 07/30/2026 at 07:30, 6 hours 47 minutes ago Half-year 2026: Accor shows its agility in a challenging global environment
Published on 07/30/2026 at 07:00, 7 hours 17 minutes ago Mersen 2026 guidance raised after strong momentum in the first half
